Bio-Rad D-10 Hemoglobin Testing System Software Recall
Bio-Rad is recalling D-10 Hemoglobin Testing Systems because the software may occasionally generate duplicate results with incorrect sample identifiers.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, and the hazard is a software data integrity error (duplicate results with mismatched IDs) rather than a direct physical injury or high-risk pathogen exposure, fitting the criteria for moderate severity.
Plain-English summary
Bio-Rad Laboratories, Inc. is recalling the D-10 Hemoglobin Testing System, Model number 220-0220. The recall involves 483 instruments in the United States, with the number of units outside the US to be determined. The product is distributed worldwide, including in the US, Canada, and numerous international locations.
The recall is due to a rare software issue where the D-10 system might generate an extra result. This error duplicates the result from the previous sample but pairs it with the Sample ID and Injection number from the next sample. This could lead to data integrity issues in hemoglobin analysis.
Healthcare facilities and laboratories using the D-10 Hemoglobin Testing System should contact Bio-Rad Laboratories for instructions on how to address the software issue. The recall is classified as Class II by the FDA.
The recalled product
- Product
- D-10" Hemoglobin Testing System, Model number: 220-0220 Manufactured by: Bio-Rad Laboratories, Inc. 4000 Alfred Nobel Drive Hercules, CA 94545 The D-10 Hemoglobin Testing System is a single module designed for hemoglobin analysis in mid-volume laboratories. The D-10 is
- Manufacturer
- Bio-Rad Laboratories, Inc.
- Affected units
- 483
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- Model number: 220-0220
Distribution
Related recalls
Same manufacturer · Bio-Rad Laboratories, Inc.
See all →- HighToxoplasma IgM assay kits recalled over risk of false positive results
FDA (Devices) · 2025-09-10
- HighAPLS IgM Diagnostic Reagent Packs Recalled Due to Incorrect Conjugate
FDA (Devices) · 2023-05-17
- HighBioPlex 2200 Anti-CCP Reagent Pack Recalled for Reduced Diagnostic Specificity
FDA (Devices) · 2023-04-19
- HighBioPlex 2200 Anti-CCP Reagent Kit recalled due to reduced test specificity
FDA (Devices) · 2023-04-19
- HighCMV IgM EIA Diagnostic Test Recalled for Increased False Positives
FDA (Devices) · 2022-12-07
Same hazard · software error
See all →- HighQuantum Rehab R-TRAK Powered Wheelchair Controller Recalled Due to Software Issue
FDA (Devices) · 2026-08-12
- HighDASH Rapid PCR Instrument Recalled Due to Software Issue Causing False Co-infection Results
FDA (Devices) · 2026-08-12
- HighQuantum Outback Powered Wheelchair Controller Recalled Due to Unexpected Braking Risk
FDA (Devices) · 2026-08-12
- HighREMISOL Advance Software Version 2.5 Recalled for Incorrect Test Result Reporting
FDA (Devices) · 2026-08-12
- HighQuantum Rehab Q6 Edge 3 Powered Wheelchair Controller Recalled for Unexpected Braking
FDA (Devices) · 2026-08-12